Companies: 10,795·Total market cap: $144.5T
West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc.

WSTNYSEHealthcare● Active
$314.50
$-2.82(-0.89%)
Market Cap$22.2B
P/E Ratio
52W High$330.88
52W Low$206.8
Overview

West Pharmaceutical Services, Inc. (WST) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · WST · as of Jun 8, 2026

Key Statistics

EPS (TTM)$7.52wst eps ttm · wst earnings per shareEarnings history
PE Ratio (TTM)41.8×wst pe ratio ttm · wst price to earningsPE Ratio deep dive
Revenue (TTM)$3.2Bwst revenue ttm · wst annual revenueFull revenue history
Dividend Yield0.29%does wst pay dividends · wst dividend yieldDividend history
Shares Outstanding72.3Mwst shares outstanding · wst floatShares outstanding history
Next EarningsJul 23, 2026Est.wst earnings date · wst next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$3.07B▲ +6.26% YoY
202320242025
west pharmaceutical services, inc. revenue · wst revenue 2025
FY 2025Net Income$493.7M▲ +0.20% YoY
202320242025
west pharmaceutical services, inc. net income · wst profit 2025
FY 2025EPS$6.83▲ +1.19% YoY
202320242025
wst eps · west pharmaceutical services, inc. earnings per share 2025
TTM:Revenue: $3.22BNet Income: $542.7MEPS: $7.52View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy15 analystsis wst a buy · wst analyst rating
Strong Buy
0
Buy
10
Hold
4
Sell
1
Strong Sell
0
12-Month Price Target
$295.00Low
$314.50Current
$315.83Avg Target0.42% upside
$340.00High
wst price target · wst 12 month forecast

Total: 15 · Buy rate: 66.7%

The WST analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $315.83, representing +0.42% upside from the current price of $314.50.

Stock Performance

Full History
1D-0.89%
1W+0.33%
1M-3.50%
3M+27.92%
YTD+14.31%
1Y+40.55%
5Y-4.78%

About West Pharmaceutical Services, Inc.

CEOEric Green
IPO DateMar 17, 1980
Employees10,600
CountryUS

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and …

what is west pharmaceutical services, inc. · wst stock overview · west pharmaceutical services, inc. company profile · who is west pharmaceutical services, inc. ceo · wst NYSE · west pharmaceutical services, inc. headquarters · west pharmaceutical services, inc. business segments

About Stock Overview & Key Data

West Pharmaceutical Services, Inc. (WST) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NYSE since Mar 17, 1980. As of the latest trading session, WST stock price is $314.50, with a market capitalization of $22.2B. The stock has returned +40.55% over the past 12 months and +14.31% year-to-date.

According to 15 Wall Street analysts, the consensus rating for West Pharmaceutical Services, Inc. stock is Buy, with an average 12-month price target of $315.83. In fiscal year 2025, West Pharmaceutical Services, Inc. reported revenue of $3.1B and net income of $493.7M. For detailed data — including West Pharmaceutical Services, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, West Pharmaceutical Services, Inc. (WST) stock price is $314.50. The stock is traded on NYSE under the ticker symbol WST. The 52-week range is $206.80 – $330.88.

WST stock priceWST quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice